Friday, May 29, 2020 9:48:08 PM
Let me play the devil's advocate for a second. If you notice how many time in their P's, K's and Q's they emphasize that they're blinded. . I found that strange as one would assume they are, even though they may have more information than us. Is it the intent to avoid giving the appearance of timing and control of releasing "good news" so they just put on their bland face and go with their fund raising activities on their monthly or whatever schedule regardless of the prevailing share price.
We already know that the max dilution is 1.2B shares and they still have $139M left of the shelf so should not be surprised even though its disappointing. If we get positive TLD in a month or so, any short term price retracement is just a blip in the bigger scheme of things.
Perhaps it looks like LP doesn't care for shareholders and maybe she doesn't and will run roughshod over just to get to the finish line and when she gets that prize so will we.
We already know that the max dilution is 1.2B shares and they still have $139M left of the shelf so should not be surprised even though its disappointing. If we get positive TLD in a month or so, any short term price retracement is just a blip in the bigger scheme of things.
Perhaps it looks like LP doesn't care for shareholders and maybe she doesn't and will run roughshod over just to get to the finish line and when she gets that prize so will we.
Pedal to the metal
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
